Add-on Acquisition • Life Science

High Tide Acquires Remexian

On August 14, 2025, High Tide acquired life science company Remexian

Acquisition Context
  • This is High Tide’s 1st transaction in the Life Science sector.
  • This is High Tide’s 2nd transaction in Germany.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date August 14, 2025
Target Remexian
Sector Life Science
Buyer(s) High Tide
Deal Type Add-on Acquisition

Target Company

Remexian

Ludwigsfelde, Germany
Remexian is a pharmaceutical company that offers importation and wholesale of medical cannabis, and has a fully certified EU GDP warehouse. Remexian was formed in 2018 and is based in Ludwigsfelde, Germany.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

High Tide

Calgary, Alberta, Canada

Category Company
Founded 2009
Sector Consumer Products
Employees1,550
Revenue 522M CAD (2024)
DESCRIPTION

High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories. The Company’s retail segment features the Canna Cabana, KushBar, Meta Cannabis Co., Meta Cannabis Supply Co., and NewLeaf Cannabis banners, with additional locations under development across the country. High Tide has been serving consumers for over a decade through its established e-commerce platforms including Grasscity.com and Smokecartel.com, and more recently in the hemp-derived CBD space through CBDcity.com and FABCBD.com as well as its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. Its strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value. High Tide was incorporated in 2009 and is based in Calgary, Alberta.


Deal Context for Buyer #
Overall 13 of 13
Sector: Life Science 1 of 1
Type: Add-on Acquisition 12 of 12
Country: Germany 2 of 2
Year: 2025 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-01-13 Purecan

Frankfurt, Germany

Purecan is an import-oriented, pharmaceutical wholesaler that focuses on emerging cannabis markets. Purecan holds a license to import medical cannabis into Germany and is preparing to launch a telemedicine portal for medical cannabis patients in Germany, along with complete warehousing and logistics infrastructure. Purecan is based in Frankfurt, Germany.

Buy €5M